Publications
Sort:
Open Access Issue
Zinc finger protein ZNF322 promotes malignant progression of glioblastoma
Journal of Nanjing Medical University (Natural Sciences) 2026, 46(11): 1619-1630
Published: 15 November 2026
Abstract PDF (5.7 MB) Collect
Downloads:0
Objective

To investigate the expression characteristics, clinical prognostic significance, immune microenvironment correlation of zinc finger protein ZNF322 in glioblastoma (GBM), as well as its effect on the biological functions of GBM cells.

Methods

The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) databases were used to analyze the expression differences of ZNF322 in glioma and GBM tissues and its relationship with patient prognosis. Kaplan-Meier survival curves, univariate and multivariate Cox regression analyses were performed to evaluate the prognostic value of ZNF322. Single-cell transcriptome data (GSE162631) were analyzed to determine the distribution characteristics of ZNF322 in malignant cell subpopulations of GBM. The CIBERSORTx algorithm was used to assess the correlation between ZNF322 expression and immune cell infiltration. ZNF322 knockdown and overexpression models were established in U87MG cells. CCK-8 assay, wound healing assay, and flow cytometry were used to detect cell proliferation, migration, and cell cycle changes, respectively.

Results

The expression level of ZNF322 in glioma and GBM tissues was significantly higher than that in normal brain tissue (P < 0.05), and its high expression was significantly associated with adverse clinical-pathological features such as WHO grading, mutational status of isocitrate dehydrogenase, and histological type (all P < 0.01). Univariate and multivariate Cox regression analyses demonstrated that high ZNF322 expression was an independent prognostic risk factor for GBM patients (HR=1.51, 95%CI: 1.15-1.99, P=0.003). Kaplan-Meier survival curves confirmed that patients with high ZNF322 expression had significantly shorter overall survival compared to those with low expression (P < 0.01). Single-cell transcriptome analysis revealed that ZNF322 was predominantly enriched in malignant cell subpopulations resembling oligodendrocytes-like and oligodendrocyte progenitors-like. Immunohistochemical infiltration analysis showed that ZNF322 exhibited negative correlations with immune cells such as natural killer cells and dendritic cells, suggesting its involvement in the remodeling of the GBM immune microenvironment. Functional enrichment analysis indicated that upregulated ZNF322 was significantly enriched in pathways related to chromosome segregation and cell cycle, whereas downregulated ZNF322 was enriched in pathways involving synaptic signaling regulation and neurotransmitter transport. In vitro, ZNF322 knockdown inhibited U87MG cell proliferation and migration and induced G0/G1-phase arrest; overexpression produced the opposite effects and increased the proportion of cells in G2/M phase.

Conclusion

ZNF322 is highly expressed in GBM and is closely associated with poor patient prognosis. It may participate in the malignant progression of GBM by regulating the cell cycle and immune microenvironment. ZNF322 has the potential to serve as a prognostic biomarker and a molecular therapeutic target for GBM.

Open Access Issue
Study on the pathogenic role of transcription factor ZNF326 in acute T-cell leukemia cells
Journal of Nanjing Medical University (Natural Sciences) 2026, 46(10): 1492-1498
Published: 15 October 2026
Abstract PDF (1.3 MB) Collect
Downloads:0
Objective

To explore the pathogenic role of transcription factor zinc finger protein 326 (ZNF326) in T-cell acute lymphoblastic leukemia (T-ALL).

Methods

The expression of ZNF326 in T-ALL tissues was analyzed using the TARGET database. Small interfering RNA (siRNA) technology was used to knock down the expression of the ZNF326 and serpin family B member 2 (SERPINB2) genes in Jurkat cells, and lentiviral transfection was performed to overexpress ZNF326 gene in Jurkat cells. Reverse transcription quantitative polymerase chain reaction (RT-qPCR) and Western blot were used to verify the knockdown and overexpression efficiency. CCK-8 cell proliferation assay was performed to detect the proliferative capacity of cells after ZNF326 knockdown and overexpression, respectively, and to verify the effect of knocking down its downstream target gene SERPINB2 on cell proliferation. Flow cytometry was used to detect the effect of ZNF326 knockdown on apoptosis and cell cycle in T-ALL cells. RNA sequencing (RNA-seq) was performed to identify the downstream target genes of ZNF326 overexpression.

Results

Knockdown of ZNF326 significantly inhibited the proliferation of T-ALL cells and induced G1 phase cell cycle arrest. Knockdown of ZNF326 downregulated the expression of SERPINB2, and specific knockdown of SERPINB2 also effectively inhibited the proliferation of T-ALL cells.

Conclusion

ZNF326 may promote the proliferation of T-ALL cells by regulating the expression of SERPINB2, and may serve asa novel therapeutic target for T-ALL.

Total 2